Post-approval safety study of RSV prefusion F subunit-based vaccine (RSVpreF)

Researchers from the Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute have published the sequential surveillance findings for ten prespecified safety outcomes of exposure to RSVpreF during pregnancy over the course of its first vaccination season in the US. More information is available here.

Photo by www.kaboompics.com